Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993–2007

Majoor, Christof J.; Magis-Escurra, Cecile; van Ingen, Jakko; Boeree, Martin J.; van Soolingen, Dick

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993–2007

Published Date:

Mar 2011

Source:

Emerg Infect Dis. 17(3):457-463.

[PDF-289.24 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Majoor, Christof J. ; Magis-Escurra, Cecile ; van Ingen, Jakko ; Boeree, Martin J. ; van Soolingen, Dick ;

Description:

In the Netherlands, 1.4% of tuberculosis (TB) cases are caused by Mycobacterium bovis. After we admitted 3 patients with M. bovis infections to our reference hospital, we conducted a retrospective analysis of all M. bovis disease in the Netherlands during 1993-2007. We analyzed data from 231 patients for clinical, demographic, treatment, and outcome characteristics and for risk factors. Most patients were native Dutch (n = 138; 59.7%) or Moroccan (n = 54; 23.4%). Disease was mainly extrapulmonary (n = 136; 58.9%). Although 95 patients had pulmonary disease, person-to-person transmission did not occur, as shown by structural DNA fingerprinting analysis. Lymph node TB was more likely to develop in women (p<0.0001), whereas pulmonary M. bovis disease developed more frequently in men (p<0.0001). Diagnosis was accurate but delayed and led to inadequate treatment in 26% of the cases. Proportion of deaths from M. bovis disease was higher than that for M. tuberculosis disease.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	10-1111_finalR.nxml	text/plain
	license.txt	text/plain
	10-1111-F1.gif	image/gif
	10-1111-F1.jpg	image/jpeg
	10-1111-F2.gif	image/gif
	10-1111-F2.jpg	image/jpeg
	10-1111-F3.gif	image/gif
	10-1111-F3.jpg	image/jpeg
	10-1111-F4.gif	image/gif
	10-1111-F4.jpg	image/jpeg

No Related Documents.

You May Also Like:

Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains

Personal Author:

Kremer, Kristin; van der Werf, Marieke J.; Au, Betty K.Y.; Anh, Dang D.; Kam, Kai M.; Rogier van Doorn, H.; Borgdorff, Martien W.; van Soolingen, Dick;

Published Date:

Feb 2009

Source:

Emerg Infect Dis. 15(2):335-339.

Description:

The frequency of typical and atypical Beijing strains of Mycobacterium tuberculosis was determined in the Netherlands; Vietnam; and Hong Kong Special Administrative Region, People's Republic of China. The strains' associations with drug resistance, M...

File Type:

[PDF - 277.91 KB]
Epidemiology of Human Mycobacterium bovis Disease, California, USA, 2003–2011

Personal Author:

Gallivan, Mark; Shah, Neha; Flood, Jennifer;

Published Date:

Mar 2015

Source:

Emerg Infect Dis. 21(3):435-443.

Description:

We conducted a retrospective review of California tuberculosis (TB) registry and genotyping data to evaluate trends, analyze epidemiologic differences between adult and child case-patients with Mycobacterium bovis disease, and identify risk factors f...

File Type:

[PDF - 528.11 KB]
Tokyo-172 BCG Vaccination Complications, Taiwan

Personal Author:

Jou, Ruwen; Huang, Wei-Lun; Su, Wei-Ju;

Published Date:

Sep 2009

Source:

Emerg Infect Dis. 15(9):1525-1526.

File Type:

[PDF - 364.88 KB]
Spread of Extensively Drug-resistant Tuberculosis

Personal Author:

Samper, Sofía; Martín, Carlos;

Published Date:

Apr 2007

Source:

Emerg Infect Dis. 13(4):647-648.

File Type:

[PDF - 27.54 KB]
Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis

Personal Author:

Scott, Colleen; Cavanaugh, Joseph S.; Silk, Benjamin J.; Ershova, Julia; Mazurek, Gerald H.; LoBue, Philip A.; Moonan, Patrick K.;

Published Date:

Mar 2017

Source:

Emerg Infect Dis. 23(3):456-462.

Description:

Current US guidelines recommend longer treatment for tuberculosis (TB) caused by pyrazinamide-resistant organisms (e.g., Mycobacterium bovis) than for M. tuberculosis TB. We compared treatment response times for patients with M. bovis TB and M. tuber...

File Type:

[PDF - 1.02 MB]